‌

Chrysalis BioTherapeutics, Inc. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Chrysalis Biotherapeutics, Inc. for $2,789,079.0 USD from the U.S. Department of Health & Human Services.

Is a

SBIR/STTR Award Recipient

Government Agency

Award Type

SBIR0

Contract Number (US Government)

2R44AI086135-020

Award Phase

Phase II0

Award Amount (USD)

2,789,0790

End Date

March 31, 2019

No article content yet.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like Chrysalis BioTherapeutics, Inc. SBIR Phase II Award,

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.